Tags

Type your tag names separated by a space and hit enter

Should COVID-19 Concern Nephrologists? Why and to What Extent? The Emerging Impasse of Angiotensin Blockade.
Nephron. 2020; 144(5):213-221.N

Abstract

Here, we review the most recent findings on the effects of SARS-CoV-2 infection on kidney diseases, including acute kidney injury, and examine the potential effects of ARBs on the outcomes of patients with COVID-19. Lastly, we discuss the clinical management of COVID-19 patients with existing chronic renal disorders, particularly those in dialysis and with kidney transplants.

Authors+Show Affiliations

Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Centro Anna Maria Astori, Science and Technology Park Kilometro Rosso, Bergamo, Italy.Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Centro Anna Maria Astori, Science and Technology Park Kilometro Rosso, Bergamo, Italy.Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Centro Anna Maria Astori, Science and Technology Park Kilometro Rosso, Bergamo, Italy, giuseppe.remuzzi@marionegri.it. Department of Biomedical and Clinical Sciences, University of Milan, Milan, Italy, giuseppe.remuzzi@marionegri.it.

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

32203970

Citation

Perico, Luca, et al. "Should COVID-19 Concern Nephrologists? Why and to what Extent? the Emerging Impasse of Angiotensin Blockade." Nephron, vol. 144, no. 5, 2020, pp. 213-221.
Perico L, Benigni A, Remuzzi G. Should COVID-19 Concern Nephrologists? Why and to What Extent? The Emerging Impasse of Angiotensin Blockade. Nephron. 2020;144(5):213-221.
Perico, L., Benigni, A., & Remuzzi, G. (2020). Should COVID-19 Concern Nephrologists? Why and to What Extent? The Emerging Impasse of Angiotensin Blockade. Nephron, 144(5), 213-221. https://doi.org/10.1159/000507305
Perico L, Benigni A, Remuzzi G. Should COVID-19 Concern Nephrologists? Why and to what Extent? the Emerging Impasse of Angiotensin Blockade. Nephron. 2020;144(5):213-221. PubMed PMID: 32203970.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Should COVID-19 Concern Nephrologists? Why and to What Extent? The Emerging Impasse of Angiotensin Blockade. AU - Perico,Luca, AU - Benigni,Ariela, AU - Remuzzi,Giuseppe, Y1 - 2020/03/23/ PY - 2020/03/13/received PY - 2020/03/17/accepted PY - 2020/3/24/pubmed PY - 2020/5/28/medline PY - 2020/3/24/entrez KW - Angiotensin receptor blockers KW - Angiotensin-converting enzyme inhibitors KW - COVID-19 KW - Renal and cardiac side effects KW - SARS-CoV-2 KW - Severe acute respiratory syndrome coronavirus SP - 213 EP - 221 JF - Nephron JO - Nephron VL - 144 IS - 5 N2 - Here, we review the most recent findings on the effects of SARS-CoV-2 infection on kidney diseases, including acute kidney injury, and examine the potential effects of ARBs on the outcomes of patients with COVID-19. Lastly, we discuss the clinical management of COVID-19 patients with existing chronic renal disorders, particularly those in dialysis and with kidney transplants. SN - 2235-3186 UR - https://www.unboundmedicine.com/medline/citation/32203970/Should_COVID_19_Concern_Nephrologists_Why_and_to_What_Extent_The_Emerging_Impasse_of_Angiotensin_Blockade_ L2 - https://www.karger.com?DOI=10.1159/000507305 DB - PRIME DP - Unbound Medicine ER -